Source:http://linkedlifedata.com/resource/pubmed/id/12186528
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2002-8-20
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
1539-3704
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
20
|
| pubmed:volume |
137
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
296-7; author reply 296-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12186528-Adult,
pubmed-meshheading:12186528-Antibodies, Monoclonal,
pubmed-meshheading:12186528-Female,
pubmed-meshheading:12186528-Humans,
pubmed-meshheading:12186528-Recurrence,
pubmed-meshheading:12186528-Sarcoidosis,
pubmed-meshheading:12186528-Tuberculosis, Pulmonary,
pubmed-meshheading:12186528-Tumor Necrosis Factor-alpha
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Infliximab therapy for complicated sarcoidosis.
|
| pubmed:publicationType |
Letter,
Comment,
Case Reports
|